Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly R F, Rolston K
Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77230-1402, USA.
Eur J Clin Microbiol Infect Dis. 2007 Aug;26(8):549-56. doi: 10.1007/s10096-007-0320-6.
Simultaneously drawn quantitative blood cultures are used to diagnose catheter-related bloodstream infections. We conducted this study to determine the frequency with which central venous catheters were the source of bloodstream infections detected through paired positive blood cultures drawn from cancer patients and the potential for quantitative blood cultures to help predict outcome in neutropenic and non-neutropenic patients. From September 1999 to November 2000, we identified 169 patients with bloodstream infections. Of all bloodstream infections, 56% were catheter-related bloodstream infections. Gram-positive bacteremia was found to be catheter-related in 55% and 69% of patients with hematologic malignancy and solid tumors, respectively, whereas gram-negative bacteremia was catheter-related in only 19% of patients with underlying hematologic malignancy and in 60% of patients with solid tumor (P = 0.01). By multivariate analysis, poor response was associated with critical illness and persistent neutropenia (P < 0.01). In neutropenic patients with catheter-related bloodstream infections, peripheral quantitative blood cultures of >or=100 CFU/mL was also associated with poor response (P = 0.05). Central venous catheters were the major source of bloodstream infection, particularly in patients with solid tumors. In addition to critical illness and persistent neutropenia, quantitative blood cultures might be useful in predicting outcomes for neutropenic patients with catheter-related bloodstream infections.
同时采集的定量血培养用于诊断导管相关血流感染。我们开展这项研究以确定中心静脉导管作为从癌症患者采集的配对阳性血培养中检测到的血流感染源的频率,以及定量血培养帮助预测中性粒细胞减少和非中性粒细胞减少患者预后的可能性。1999年9月至2000年11月,我们确定了169例血流感染患者。在所有血流感染中,56%为导管相关血流感染。在血液系统恶性肿瘤和实体瘤患者中,分别有55%和69%的革兰氏阳性菌血症与导管相关,而在有潜在血液系统恶性肿瘤的患者中,仅19%的革兰氏阴性菌血症与导管相关,在实体瘤患者中这一比例为60%(P = 0.01)。通过多变量分析,反应不佳与危重病和持续性中性粒细胞减少相关(P < 0.01)。在患有导管相关血流感染的中性粒细胞减少患者中,外周定量血培养≥100 CFU/mL也与反应不佳相关(P = 0.05)。中心静脉导管是血流感染的主要来源,尤其是在实体瘤患者中。除了危重病和持续性中性粒细胞减少外,定量血培养可能有助于预测患有导管相关血流感染的中性粒细胞减少患者的预后。